Publications by authors named "Han-Xi Yu"
Systemic chemotherapy improves outcome of hepatocellular carcinoma patients treated with transarterial chemoembolization.
Hepatobiliary Pancreat Dis Int
November 2024
Article Synopsis
- Transarterial chemoembolization (TACE) with or without tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) is evaluated for its effectiveness as neoadjuvant therapy in hepatocellular carcinoma (HCC), focusing on the relationship between pathologic response and patient prognosis.
- In a study involving 481 HCC patients, 15.8% achieved complete pathologic response (CPR), and 37.2% reached major pathologic response (MPR), with improved median recurrence-free survival (RFS) noted in those achieving MPR or CPR.
- Analysis identified independent risk factors affecting recurrence-free survival, including failure to reach MPR, positive HBsAg, multiple lesions, and